Viewing Study NCT07115550


Ignite Creation Date: 2025-12-24 @ 4:59 PM
Ignite Modification Date: 2026-02-02 @ 4:32 AM
Study NCT ID: NCT07115550
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-08-11
First Post: 2025-08-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Single-center, Single-arm, Phase II Clinical Study of Iparomlimab and Tuvonralimab Injection Combined With Regorafenib in the Treatment of Advanced Second-line or Above Hepatocellular Carcinoma
Sponsor: Huai'an First People's Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hepatocellular Carcinoma (HCC) View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Iparomlimab and Tuvonralimab View
None regorafenib View